Shares of Oculis Holding AG (NASDAQ:OCS – Get Free Report) have been given an average recommendation of “Buy” by the nine research firms that are covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 12 month target price among analysts that have updated their coverage on […]
Related Keywords
Lombard Odier Scm , Stifel Nicolaus , Oculis Holding , Barclays Plc , Get Free Report , Marketbeat Ratings , Compagnie Lombard Odier , Lombard Odier , Get Free , Oculis Daily , Oculis , Nasdaq Ocs , Docs , Medical , Ratings , Consensus ,
vimarsana.com © 2020. All Rights Reserved.